Edgewise Therapeutics, Inc.
EWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,467,471 | $697,136 | $479,128 | $756,365 |
| - Cash | $41,666 | $86,097 | $21,993 | $15,566 |
| + Debt | $4,737 | $5,414 | $4,408 | $0 |
| Enterprise Value | $2,430,542 | $616,453 | $461,543 | $740,799 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$156,542 | -$112,625 | -$71,120 | -$42,943 |
| % Margin | – | – | – | – |
| Net Income | -$133,813 | -$100,163 | -$67,640 | -$42,813 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.45 | -1.57 | -1.26 | -0.86 |
| % Growth | 7.6% | -24.6% | -46.5% | – |
| Operating Cash Flow | -$109,028 | -$91,948 | -$52,635 | -$33,507 |
| Capital Expenditures | -$1,312 | -$5,745 | -$5,546 | -$668 |
| Free Cash Flow | -$110,340 | -$97,693 | -$58,181 | -$34,175 |